Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Jan 2011 - Blood; 117(2):1528-0020 [PMID:21030562]
[Rosenblatt J] [Vasir B] [Uhl L] [Blotta S] [Macnamara C] [Somaiya P] [Wu Z] [Joyce R] [Levine JD] [Dombagoda D] [Yuan YE] [Francoeur K] [Fitzgerald D] [Richardson P] [Weller E] [Anderson K] [Kufe D] [Munshi N] [Avigan D]

Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.
Apr 2004 - Br. J. Haematol.; 125(3):0007-1048 [PMID:15086415]
[Raje N] [Hideshima T] [Davies FE] [Chauhan D] [Treon SP] [Young G] [Tai YT] [Avigan D] [Gong J] [Schlossman RL] [Richardson P] [Kufe DW] [Anderson KC]